Special Drug Use-results Surveillance of Tabrecta Tablets
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Combination Therapy in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)
- Status
- COMPLETED
- Phase
- N/A
Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)
- Status
- COMPLETED
- Phase
- PHASE2
SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II
- Status
- COMPLETED
- Phase
- PHASE2
Study of Durvalumab or Durvalumab Plus Chemotherapy in Kras Mutation Positive and PD-L1 High (≥ 50%) NSCLC Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC（neoSCORE）
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluation of GLR2007 for Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
PD-L1 Expression in Cancer (PECan Study).
- Status
- UNKNOWN
- Phase
- NA
A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Immune Checkpoint Inhibitors and Atherosclerotic Plaque Volume
- Status
- COMPLETED
- Phase
- N/A
Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1